Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk

Women connected regimens of estrogen-only menopausal hormone therapy are astatine reduced hazard of Alzheimer's disease, a survey by Stanford Medicine investigators has found. Because estrogen-only therapy is mostly prescribed for women without a uterus, astir of these users presumably had had hysterectomies.